CHAT and Alzheimer disease: In AD patients, a dramatic decrease of acetylcholine has been observed (Francis et al., 1999), which was related to a decrease in enzyme choline acetyltransferase (ChAT) activity and an increase in acetylcholinesterase (AChE) activity (Bieschke et al., 2005).